0001181431-15-007778.txt : 20150602 0001181431-15-007778.hdr.sgml : 20150602 20150602170203 ACCESSION NUMBER: 0001181431-15-007778 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150601 FILED AS OF DATE: 20150602 DATE AS OF CHANGE: 20150602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYNOSURE INC CENTRAL INDEX KEY: 0000885306 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043125110 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 CARLISLE ROAD CITY: WESTFORD STATE: MA ZIP: 01886 BUSINESS PHONE: (978) 256-4200 MAIL ADDRESS: STREET 1: 5 CARLISLE ROAD CITY: WESTFORD STATE: MA ZIP: 01886 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Biagioni Ettore V CENTRAL INDEX KEY: 0001345970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51623 FILM NUMBER: 15907618 MAIL ADDRESS: STREET 1: C/O CYNOSURE, INC. STREET 2: 5 CARLISLE ROAD CITY: WESTFORD STATE: MA ZIP: 01886 4 1 rrd425422.xml EB EXERCISE X0306 4 2015-06-01 0 0000885306 CYNOSURE INC CYNO 0001345970 Biagioni Ettore V C/O CYNOSURE, INC. 5 CARLISLE ROAD WESTFORD MA 01886 1 0 0 0 Class A Common Stock 2015-06-01 4 M 0 6000 13.97 A 11220 D Class A Common Stock 2015-06-01 4 M 0 2000 11.89 A 13220 D Class A Common Stock 2015-06-01 4 M 0 8000 21.16 A 21220 D Class A Common Stock 2015-06-01 4 M 0 8000 23.45 A 29220 D Class A Common Stock 2015-06-01 4 S 0 24000 36.2497 D 5220 D Director Stock Option (right to buy) 13.97 2015-06-01 4 M 0 6000 0 D 2021-05-12 Class A Common Stock 6000 0 D Director Stock Option (right to buy) 11.89 2015-06-01 4 M 0 2000 0 D 2021-07-27 Class A Common Stock 2000 0 D Director Stock Option (right to buy) 21.16 2015-06-01 4 M 0 8000 0 D 2022-05-09 Class A Common Stock 8000 0 D Director Stock Option (right to buy) 23.45 2015-06-01 4 M 0 8000 0 D 2023-06-24 Class A Common Stock 8000 0 D The number of shares include 5,220 shares currently owned plus 6,000 shares from the exercise of stock options on June 1, 2015. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $36.00 to $36.71 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The option became exercisable as to 100% of the shares on the anniversary of the 5/12/2011 grant date. The option became exercisable as to 100% of the shares on the anniversary of the 7/27/2011 grant date. The option became exercisable as to 100% of the shares on the anniversary of the 5/9/2012 grant date. The option became exercisable as to 100% of the shares on the anniversary of the 6/24/2013 grant date. Timothy W. Baker, Attorney-in-Fact 2015-06-02